The Yamagata Bank,Ltd.
8344・Prime Market・Banks
Governance
As a company with an Audit and Supervisory Committee, the Board of Directors consists of 10 directors (of which 5 are outside directors and 5 are independent officers). A Governance Committee (a voluntary advisory committee, with independent outside officers comprising a majority and serving as chairperson), which also functions as a nomination and compensation committee, has been established. In addition, an executive officer system was introduced in June 2024 to strengthen the separation of oversight and execution.
Risk Management
The Risk Management Division centrally manages various risks based on the "Integrated Risk Management Regulations," with the Board of Directors reviewing the basic policy semi-annually. The Risk Management Committee and ALM Committee are held regularly as managing directors' meetings, and the Audit Division conducts independent internal audits covering all departments, branches, and affiliated companies.
Shareholder Returns
For FY2026 (ending March 2026), an annual dividend of ¥84 (interim ¥28, year-end ¥56) was implemented, with a payout ratio of 40.4%. For FY2027 (ending March 2027), an annual dividend of ¥98 (interim ¥49, year-end ¥49) is forecast. Share buybacks (up to 170,000 shares, ¥500 million) are also being conducted to improve capital efficiency.
Dividend Policy
Consolidated payout ratio of 40.4% (FY2026 (ending March 2026) actual). For FY2026 (ending March 2026), an interim dividend of ¥28 per share and a year-end dividend of ¥56 (increased from the initially planned ¥50) were implemented, for an annual total of ¥84, with total dividends paid of ¥2,652 million. For FY2027 (ending March 2027), an annual dividend of ¥98 (interim ¥49, year-end ¥49; payout ratio of 40.4%) is forecast. Dividends are paid twice a year (interim and year-end). Note that the FY2026 (ending March 2026) year-end dividend was increased from the initially planned ¥50 to ¥56.
ESG
The company supports the TCFD recommendations and has set a goal of achieving carbon neutrality for Scope 1 and 2 emissions by FY2030, achieving a 71.0% reduction in FY2025 compared to FY2013. It has set a cumulative sustainable finance target of ¥500.0 billion (by FY2030), and in terms of human capital, has been certified as an Excellent Health Management Corporation for nine consecutive years, achieving an engagement score of 70.2 points (exceeding the target of over 68 points). The company has set KPIs and is advancing initiatives in the areas of climate change, regional revitalization, and human capital.
Last updated: June 18, 2026